Organogenesis Holdings Inc.

NASDAQ:ORGO

3.19 (USD) • At close December 27, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Revenue 115.177130.234109.97699.651108.531117.316107.642115.516116.859121.40198.117128.558113.753123.196102.552106.807100.79968.9661.73274.64564.26564.94857.12363.5990006.5870000.061000
Cost of Revenue 26.79633.60532.35731.8725.78926.31626.60727.1126.17726.65225.0832.59726.16729.9425.49525.5222.96420.04218.79320.39119.13119.44616.9817.512.2490.9431.1591.2982.8530.2220.2190.1780.0140.0010.016
Gross Profit 88.38196.62977.61967.78182.7429181.03588.40690.68294.74973.03795.96187.58693.25677.05781.28777.83548.91842.93954.25445.13445.50240.14346.089-2.249-0.943-1.1595.289-2.853-0.222-0.219-0.117-0.014-0.001-0.016
Gross Profit Ratio 0.7670.7420.7060.680.7620.7760.7530.7650.7760.780.7440.7460.770.7570.7510.7610.7720.7090.6960.7270.7020.7010.7030.7250000.803000-1.917000
Reseach & Development Expenses 10.34415.58712.8111.7710.4710.93811.20211.3959.57510.2058.5878.268.9537.326.2096.2993.7094.6685.413.643.9243.8643.3713.09100000000000
General & Administrative Expenses 00047.908070.317063.481000000000000000000000000000
Selling & Marketing Expenses 0005.2250004.812000000000000000000000000000
SG&A 71.79576.5466.14653.13364.22270.31773.83468.29379.32872.60963.57867.2562.36962.34958.23253.21751.14646.50252.61352.36849.47548.95748.89347.47800000000000
Other Expenses 00-2.515-2.2290.0310.0280.0230.0060.005-0.021-0.003-0.009-0.0190.018-0.0030.0070.0440.0250.0210.002-0.001-0.120.1320.155.722001.2982.8530.2220.2190.1780.0140.0010.016
Operating Expenses 82.13992.12781.47167.13274.69281.25585.03679.68888.90382.81472.16575.5171.32269.66964.44159.51654.85551.1758.02356.00853.39952.82152.26450.5695.722001.2982.8530.2220.2190.1780.0140.0010.016
Operating Income 6.242-13.892-3.8520.6498.059.745-3.9784.1631.77911.9350.87220.45116.26423.58712.61621.77122.98-2.252-15.084-1.754-8.265-7.319-12.121-4.48-2.249-0.943-1.159-1.298-2.853-0.222-0.2190.178-0.014-0.001-0.016
Operating Income Ratio 0.054-0.107-0.0350.0070.0740.083-0.0370.0360.0150.0980.0090.1590.1430.1910.1230.2040.228-0.033-0.244-0.023-0.129-0.113-0.212-0.07000-0.1970002.917000
Total Other Income Expenses Net -0.419-0.648-0.491-0.504-0.413-0.566-0.6260.036-0.567-0.751-0.74-0.862-3.384-2.413-2.473-2.881-1.974-2.887-1.194-2.602-2.428-2.307-3.508-22.6997.1851.31.0230.80.7360.6020.360000
Income Before Tax 5.823-14.54-4.343-1.7967.6379.179-4.6278.7541.21211.1840.13219.58912.8821.17410.14318.8921.006-5.139-16.278-4.356-10.693-9.626-15.629-9.2534.9360.357-0.136-0.498-2.1170.380.141-0.178-0.014-0.001-0.016
Income Before Tax Ratio 0.051-0.112-0.039-0.0180.070.078-0.0430.0760.010.0920.0010.1520.1130.1720.0990.1770.208-0.075-0.264-0.058-0.166-0.148-0.274-0.145000-0.076000-2.917000
Income Tax Expense -6.5082.503-2.243-1.228-4.473.863-1.6581.2680.9972.440.045-32.1060.3030.4870.20.3960.0720.0270.0350.0420.0480.0230.0370.00200000000000
Net Income 12.331-17.043-2.1-0.56812.1075.316-2.9697.4860.2158.7440.08751.69512.57720.6879.94318.49420.934-5.166-16.313-4.398-10.741-9.649-15.666-9.2554.9360.357-0.136-0.498-2.1170.380.141-0.178-0.014-0.001-0.016
Net Income Ratio 0.107-0.131-0.019-0.0060.1120.045-0.0280.0650.0020.0720.0010.4020.1110.1680.0970.1730.208-0.075-0.264-0.059-0.167-0.149-0.274-0.146000-0.076000-2.917000
EPS 0.093-0.13-0.016-0.0040.0920.041-0.0230.0570.0020.0680.0010.40.10.160.080.160.2-0.05-0.16-0.045-0.12-0.11-0.17-0.12-0.19-0.3-0.002-0.053-0.23-0.02-0.02-0.023-0.002-0-0
EPS Diluted 0.092-0.13-0.016-0.0040.0910.04-0.0230.0570.0020.0660.0010.390.090.150.070.150.19-0.049-0.16-0.045-0.12-0.11-0.17-0.12-0.19-0.3-0.002-0.053-0.23-0.02-0.02-0.023-0.002-0-0
EBITDA 10.698-9.720.1445.03613.92615.1841.88513.3096.29416.4652.43725.26519.09427.34415.99523.97925.816-0.52-12.0490.6-5.945-5.081-11.432-47.206-2.249-0.943-1.159-0.498-2.853-0.222-0.219-0.178-0.014-0.001-0.016
EBITDA Ratio 0.093-0.0580.0210.070.0740.1130.0180.0750.0540.1360.0540.1590.1840.2220.1560.2040.247-0.008-0.216-0.023-0.093-0.078-0.168-0.068000-0.197000-2.917000